SEMA4C and cervical cancer: In our previous studies, tumor-associated lymphatic endothelial cells (LECs) were found for the first time to produce soluble Sema4C (sSema4C) through MMP cleavage, and increased serum sSema4C was detected in patients with breast cancer and cervical cancer and in those with metastasis.